Brainsway (BRSYF) CTO reports shares, RSUs and options in Form 3

Rhea-AI Filing Summary

Brainsway Ltd. Chief Technology Officer Gilad Moiseyev filed an initial ownership report showing direct holdings of ordinary shares and equity awards. He reports 52,500 ordinary shares (including 7,500 shares and multiple restricted stock unit grants that vest in stages through March 2030). He also holds stock options over 30,000 ordinary shares, granted on March 5, 2024, with remaining options to purchase 15,000 ordinary shares vesting in equal quarterly installments until March 5, 2028. These options carry an exercise price of NIS 11.17 per share and expire on March 5, 2034. The ordinary shares may also be represented by American Depositary Shares, each currently equal to one ordinary share.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Moiseyev Gilad

Role Chief Technology Officer

Type	Security	Shares	Price	Value
holding	Stock Options (right to buy)	--	--	--
holding	Ordinary Shares	--	--	--

Holdings After Transaction: Stock Options (right to buy) — 30,000 shares (Direct); Ordinary Shares — 52,500 shares (Direct)

Footnotes (1)

1. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. This figure includes: (i) 7,500 ordinary shares and (ii) unvested restricted stock units ("RSUs"), with each RSU representing a contingent right to receive one ordinary share, as follows: (a) RSUs to receive 7,500 ordinary shares vesting in equal quarterly installments until March 5, 2028, (b) RSUs to receive 10,000 ordinary shares with 2,500 vesting on November 10, 2026 and the remainder vesting in equal quarterly installments until November 10, 2029 and (c) RSUs to receive 27,500 ordinary shares with 6,875 vesting on March 10, 2027 and the remainder vesting in equal quarterly installments until March 10, 2030. Stock options were granted on March 5, 2024, with the remaining options to purchase 15,000 ordinary shares vesting in equal quarterly installments until March 5, 2028. The exercise price is NIS 11.17 per share.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Moiseyev Gilad

(Last) (First) (Middle)

16 HARTUM STREET, RAD TOWER, 14TH FLOOR

HAR HAHOTZVIM

(Street)

JERUSALEM 9777516

(City) (State) (Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Brainsway Ltd. [ BWAY ]

3a. Foreign Trading Symbol
[BWAY]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Technology Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares(1)(2)	52,500	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (right to buy)	(3)	03/05/2034	Ordinary Shares(1)	30,000	(4)	D

Explanation of Responses:

1. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

2. This figure includes: (i) 7,500 ordinary shares and (ii) unvested restricted stock units ("RSUs"), with each RSU representing a contingent right to receive one ordinary share, as follows: (a) RSUs to receive 7,500 ordinary shares vesting in equal quarterly installments until March 5, 2028, (b) RSUs to receive 10,000 ordinary shares with 2,500 vesting on November 10, 2026 and the remainder vesting in equal quarterly installments until November 10, 2029 and (c) RSUs to receive 27,500 ordinary shares with 6,875 vesting on March 10, 2027 and the remainder vesting in equal quarterly installments until March 10, 2030.

3. Stock options were granted on March 5, 2024, with the remaining options to purchase 15,000 ordinary shares vesting in equal quarterly installments until March 5, 2028.

4. The exercise price is NIS 11.17 per share.

	/s/ Gilad Moiseyev	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the Brainsway (BRSYF) Form 3 filing by Gilad Moiseyev show?

The Form 3 shows Gilad Moiseyev’s initial ownership as Chief Technology Officer, including 52,500 ordinary shares and several equity awards. It details restricted stock units vesting through 2030 and stock options over 30,000 shares with a set exercise price and expiry.

How many Brainsway (BRSYF) ordinary shares does Gilad Moiseyev report owning?

Gilad Moiseyev reports beneficial ownership of 52,500 ordinary shares. This figure includes 7,500 directly held shares plus multiple restricted stock unit grants, each RSU representing a contingent right to receive one ordinary share, vesting quarterly over several years.

What stock option awards are disclosed for Gilad Moiseyev in the Brainsway (BRSYF) Form 3?

The filing discloses stock options granted on March 5, 2024, over 30,000 ordinary shares. The remaining options to purchase 15,000 shares vest in equal quarterly installments until March 5, 2028, with an exercise price of NIS 11.17 per share and expiration in 2034.

How are RSUs structured in Gilad Moiseyev’s Brainsway (BRSYF) equity holdings?

His holdings include RSUs to receive 7,500, 10,000 and 27,500 ordinary shares, each series vesting on different schedules. Vesting occurs in specified initial tranches and then in equal quarterly installments until dates ranging from March 2028 through March 2030.

Are Brainsway (BRSYF) ordinary shares in this Form 3 linked to American Depositary Shares?

Yes. The filing notes that Brainsway’s ordinary shares may be represented by American Depositary Shares. Each American Depositary Share currently represents one ordinary share, aligning the ADS and ordinary share count on a one-for-one basis.

Does the Brainsway (BRSYF) Form 3 indicate any recent insider buying or selling by Gilad Moiseyev?

The Form 3 functions as an initial ownership statement and does not detail explicit buy or sell transactions. Instead, it lists Moiseyev’s existing holdings in ordinary shares, restricted stock units, and stock options as of the reporting date.